Quest Diagnostics, Inc (NYSE:DGX) shares, rose in value on Friday, December 13, with the stock price down by -0.69% to the previous day’s close as strong demand from buyers drove the stock to $155.00.
Actively observing the price movement in the last trading, the stock closed the session at $156.07, falling within a range of $154.82 and $157.06. The value of beta (5-year monthly) was 0.891 whereas the PE ratio was 20.81 over 12-month period. Referring to stock’s 52-week performance, its high was $165.32, and the low was $123.04. On the whole, DGX has fluctuated by -3.46% over the past month.
With the market capitalization of Quest Diagnostics, Inc currently standing at about $17.30 billion, investors are eagerly awaiting this quarter’s results, scheduled for in January. The company’s Forward Dividend Ratio is 2.96, with its dividend yield at 1.91%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 9.83B, with a low estimate of 2.55B and a high estimate of 2.66B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 2.58B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that DGX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 3.20, with the price of DGX currently trading nearly -3.31% and -0.84% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.95, while the 7-day volatility ratio is showing 2.03% which for the 30-day chart, stands at 1.76%. Furthermore, Quest Diagnostics, Inc (DGX)’s beta value is 0.89, and its average true range (ATR) is 2.82.
A comparison of Quest Diagnostics, Inc (DGX) with its peers suggests the former has fared considerably weaker in the market. DGX showed an intraday change of -0.69% in last session, and over the past year, it grew by 9.84%%.
Data on historical trading for Quest Diagnostics, Inc (NYSE:DGX) indicates that the trading volumes over the past 10 days have averaged 0.78 and over the past 3 months, they’ve averaged 807.24K. According to company’s latest data on outstanding shares, there are 112.00 million shares outstanding.
Nearly 0.50% of Quest Diagnostics, Inc’s shares belong to company insiders and institutional investors own 89.54% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.04 million shares as on 2024-11-29, resulting in a short ratio of 2.34. According to the data, the short interest in Quest Diagnostics, Inc (DGX) stood at 209.00 of shares outstanding as of 2024-11-29; the number of short shares registered in 2024-10-31 reached 2.38 million. The stock has risen by 12.42% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the DGX stock heading into the next quarter.
